FERRERO, Ivana
 Distribuzione geografica
Continente #
NA - Nord America 3.191
EU - Europa 1.697
AS - Asia 1.078
SA - Sud America 39
AF - Africa 13
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 2
Totale 6.033
Nazione #
US - Stati Uniti d'America 3.128
CN - Cina 572
IT - Italia 535
IE - Irlanda 192
SE - Svezia 167
DE - Germania 160
FI - Finlandia 122
UA - Ucraina 122
SG - Singapore 120
FR - Francia 114
KR - Corea 93
GB - Regno Unito 77
VN - Vietnam 73
JP - Giappone 68
PL - Polonia 64
CA - Canada 54
IN - India 37
BR - Brasile 24
BE - Belgio 21
IR - Iran 20
AT - Austria 18
NL - Olanda 18
TW - Taiwan 18
HK - Hong Kong 16
TR - Turchia 15
NO - Norvegia 14
AU - Australia 13
ES - Italia 13
BG - Bulgaria 10
MY - Malesia 10
BY - Bielorussia 8
CL - Cile 8
PT - Portogallo 8
TH - Thailandia 8
MX - Messico 7
SN - Senegal 7
BD - Bangladesh 6
CZ - Repubblica Ceca 6
IL - Israele 6
PH - Filippine 6
CO - Colombia 5
RU - Federazione Russa 5
CH - Svizzera 4
UZ - Uzbekistan 4
AE - Emirati Arabi Uniti 3
DK - Danimarca 3
HU - Ungheria 3
RO - Romania 3
SI - Slovenia 3
EU - Europa 2
ID - Indonesia 2
IS - Islanda 2
LT - Lituania 2
NG - Nigeria 2
AM - Armenia 1
AR - Argentina 1
EG - Egitto 1
GR - Grecia 1
KE - Kenya 1
LV - Lettonia 1
MK - Macedonia 1
MQ - Martinica 1
PA - Panama 1
SC - Seychelles 1
UY - Uruguay 1
ZA - Sudafrica 1
Totale 6.033
Città #
Chandler 389
Beijing 329
Fairfield 303
Ashburn 203
Dublin 188
Torino 178
Houston 169
Woodbridge 155
Ann Arbor 139
Wilmington 132
Seattle 130
Cambridge 101
Jacksonville 95
Singapore 84
Villeurbanne 73
Medford 71
Nyköping 65
Pisa 62
Princeton 60
Dearborn 57
Warsaw 56
Dong Ket 51
Milan 47
Turin 37
Fremont 34
Redwood City 33
Ottawa 31
Shanghai 30
Guangzhou 27
Boston 22
Nanjing 20
San Diego 18
San Mateo 17
Brussels 15
Taipei 14
Vienna 14
New York 13
Zhengzhou 13
Boardman 12
Stavanger 12
Toronto 12
Düsseldorf 11
Santa Clara 11
Los Angeles 10
Helsinki 9
Norwalk 9
Phoenix 9
Xian 9
Wuhan 8
Hangzhou 7
London 7
Tianjin 7
Buffalo 6
Chicago 6
Detroit 6
Dhaka 6
Hefei 6
Kuala Lumpur 6
Padova 6
Pavia 6
Santiago 6
Silver Spring 6
Washington 6
Buk-gu 5
Genova 5
Grafing 5
Groningen 5
Jinan 5
Kunming 5
Malo 5
Philadelphia 5
Pozzolo Formigaro 5
Rome 5
San Antonio 5
Tokyo 5
Verona 5
Central 4
Curitiba 4
Delft 4
Galway 4
Heidelberg 4
Istanbul 4
Kagoshima 4
Montréal 4
Mumbai 4
Nuremberg 4
Paris 4
Prague 4
Seoul 4
Shenyang 4
Shinjuku 4
Auburn Hills 3
Bangkok 3
Bologna 3
Brasília 3
Central District 3
Changchun 3
Changsha 3
Cincinnati 3
Collegeville 3
Totale 3.826
Nome #
Ex vivo expanded mesenchymal stromal cell minimal quality requirements for clinical application 551
Intracellular reactive oxygen species are required for directional migration of resident and bone marrow-derived hepatic pro-fibrogenic cells. 341
Human mesenchymal stromal cell transplantation modulates neuroinflammatory milieu in a mouse model of amyotrophic lateral sclerosis. 332
Inactivated human platelet lysate with psoralen: a new perspective for mesenchymal stromal cell production in Good Manufacturing Practice conditions. 249
Dissection of the biphasic nature of hypoxia-induced motogenic action in bone marrow-derived human mesenchymal stem cells. 181
High energy shock waves enhance the cytotoxic effect of doxorubicin and methotrexate to human osteosarcoma cell lines 180
Cytokine-induced killer cells eradicate bone and soft-tissue sarcomas. 180
Mesenchymal stem cells in Amyotrophic Lateral Sclerosis 158
Myogenic potential of whole bone marrow mesenchymal stem cells in vitro and in vivo for usage in urinary incontinence. 139
Validation of analytical methods in compliance with good manufacturing practice: A practical approach 138
Stem cell therapy applications in amyotrophic lateral sclerosis 129
Cytokines induced killer cells produced in good manufacturing practices conditions: identification of the most advantageous and safest expansion method in terms of viability, cellular growth and identity 127
Bone marrow mesenchymal stem cells from healthy donors and sporadic amyotrophic lateral sclerosis patients. 124
Stem cell treatment in Amyotrophic Lateral Sclerosis. 120
Multipotent Mesenchymal Stromal Stem Cell Expansion by Plating Whole Bone Marrow at a Low Cellular Density: A More Advantageous Method for Clinical Use 118
null 116
Intrahepatic Administration of Human Liver Stem Cells in Infants with Inherited Neonatal-Onset Hyperammonemia: A Phase I Study 115
COMPARING THE IMMUNOREGULATORY EFFECTS OF MESENCHYMAL STEM CELLS ISOALTED FROM BONE MARROW, PLACENTA AND AMNIOTIC FLUID 114
Analysis of Mesenchymal Stromal Cell Engraftment After Allogeneic HSCT in Pediatric Patients: A Large Multicenter Study 102
Post-Transplant Cyclophosphamide and Tacrolimus-Mycophenolate Mofetil Combination Governs GVHD and Immunosuppression Need, Reducing Late Toxicities in Allogeneic Peripheral Blood Hematopoietic Cell Transplantation from HLA-Matched Donors 96
Intrabone cord blood hematopoietic stem cell transplantation in a subset of very high-risk pediatric patients: a safety and feasibility pilot study. 95
Inactivated GMP-compliant human platelet lysate for clinical-scale expansion of mesenchymal stem cells. 92
The activity of STI571 in human osteosarcoma cells. 90
Autologous mesenchymal stem cells: clinical applications in amyotrophic lateral sclerosis. 90
Mesenchymal stem cell chimerism following HSCT 88
Expansion of mesenchymal stem cells isolated from paediatric and adult donor bone marrow 86
Adult Stem cells and neurodegenerative diseases 85
Ex vivo-expanded bone marrow CD34(+) for acute myocardial infarction treatment: in vitro and in vivo studies. 84
High-dose thiotepa and etoposide in children with poor-prognosis brain tumors 81
Inactivated human platelet lysate is a new method to censure safer GMP-compliant MSC production. 81
PDGF-BB as mitogenic and chemotactic stimulus for bone marrow – derived human mesenchymal stem cells, putative precursors of profibrogenic myofibroblast – like cells 81
PDGF-BB is an effective mitogenic and chemotactic stimulus for bone marrow – derived human mesenchymal stem cells, putative precursors of profibrogenic myofibroblast – like cells 78
Association between elevated prolactin levels and circulating erythroid precursors in dialyzed patients 78
[The c-kit/Stem Cell Factor in the cancerogenetic process of colon-rectal carcinoma. Biological and clinical aspects] 75
Engraftment of bone marrow – derived human mesenchymal stem cells in normal and injured liver of NOD/SCID mice 75
Human mesenchymal stem cells as a two-edged sword in hepatic regenerative medicine: Engraftment and hepatocyte differentiation versus profibrogenic potential 75
Mesenchymal stem cells isolated from amniotic fluid differentiate in neuronal cells 71
Stem cell transplantation in amyotrophic lateral sclerosis patients 71
null 67
Effect of in vitro exposure of corticosteroid drugs, conventionally used in AMD treatment, on mesenchymal stem cells 67
Stem cell transplantation as consolidation therapy for children in first-remission AML: a single-center report. 66
Refreezing of cord blood hematopoietic stem cells for allogenic transplantation: in vitro and in vivo validation of a clinical phase I/II protocol in European and Italian Good Manufacturing Practice conditions 65
null 64
Mesenchymal stem cells isolated from amniotic fluid differentiate in neural cells 60
Mesenchymal Stem Cell Manufacturing for Clinical Use 59
Mesenchymal stem cell transplantation in amyotrophic lateral sclerosis: A Phase I clinical trial. 57
Neural differentiation of human mesenchymal stem cells: Evidence for expression of neural markers and eag K+ channel types 56
Amyotrophic lateral sclerosis:What goals for cell therapy? 55
STEM CELL TRANSPLANTATION IN AMYOTROPHIC LATERAL SCLEROSIS PATIENTS 47
Mesenchymal stem/stromal cells: a new ''cells as drugs'' paradigm. Efficacy and critical aspects in cell therapy 47
Human mesenchymal stem cell transplantation extends survival, improves motor performance and decreases neuroinflammation in mouse model of amyotrophic lateral sclerosis 45
null 44
Differential expression of transforming growth factors-beta1, -beta2 and -beta3in human colon carcinoma. 43
A New Human Platelet Lysate for Mesenchymal Stem Cell Production Compliant with Good Manufacturing Practice Conditions 38
Stem cells in amyotrophic lateral sclerosis: state of the art 37
The pro-apoptotic factors Fas Ligand and Trail. Molecular mechanisms, physiopathological role and therapeutic potential. 36
Validation of analytical methods in GMP: The disposable Fast Read 102® device, an alternative practical approach for cell counting 32
Full chimaeric CAR.CIK from patients engrafted after allogeneic haematopoietic cell transplant: Feasibility, anti-leukaemic potential and alloreactivity across major human leukocyte antigen barriers 27
A New Human Platelet Lysate for Mesenchymal Stem Cell Production Compliant with Good Manufacturing Practice Conditions Preserves the Chemical Characteristics and Biological Activity of Lyo‐Secretome Isolated by Ultrafiltration 27
Mesenchymal stem cells isolated from amniotic fluid differentiate in neuronal cells 25
Mesenchymal stem cells for ALS patients 24
Mesenchymal stem/stromal cell extracellular vesicles: From active principle to next generation drug delivery system 23
GMP compliant isolation and expansion of MSCs with inactivated human platelet lysate 22
State of the Art and New Trends from the 2022 Gism Annual Meeting 17
A New Paclitaxel Formulation Based on Secretome Isolated from Mesenchymal Stem Cells Shows a Significant Cytotoxic Effect on Osteosarcoma Cell Lines 13
Preclinical models of tumour-specific cytotoxic T lymphocytes in sarcoma patients 12
Generation and characterization of two primary cultures of osteosarcoma and Ewing’s sarcoma 11
Validation of the media fill method for Cytokine-Induced killer cells manufacturing process 10
Totale 6.282
Categoria #
all - tutte 16.586
article - articoli 0
book - libri 0
conference - conferenze 3.684
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.270


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020819 0 0 64 104 48 114 100 58 73 133 69 56
2020/20211.005 78 196 86 34 94 64 49 69 54 70 69 142
2021/2022785 42 35 27 65 29 47 49 63 35 73 167 153
2022/20231.053 99 81 23 109 100 278 73 55 127 20 52 36
2023/2024566 51 99 34 42 52 69 29 42 6 31 57 54
2024/202589 15 74 0 0 0 0 0 0 0 0 0 0
Totale 6.282